DoD invests in medical swab production
The US Department of Defense (DoD) has awarded Puritan Medical Products a $75.5 million investment as part of the Defence Production Act Title 3 funding.
This investment will increase swab production by 20 million units per month from May 2020 onwards and will fund a new manufacturing facility in Pittsfield, Maine. As a result, the company will be capable of expanding output to 40 million medical swabs each month.
In addition, the company will expand its workforce by employing an extra 150 people to work at the new Pittsfield site, according to Lt Col Mike Andrews, a spokesperson at the DoD.
More from Defence Notes
-
![US, Canada advance with over-the-horizon radar programmes to close NORAD surveillance gaps]()
US, Canada advance with over-the-horizon radar programmes to close NORAD surveillance gaps
Washington and Ottawa’s Arctic and homeland radar initiatives aim to strengthen early warning against cruise missiles, hypersonic weapons and long-range aerospace threats approaching North America.
-
![The speed of relevance: how companies can navigate the new era of European defence procurement]()
The speed of relevance: how companies can navigate the new era of European defence procurement
European militaries face a rapidly evolving security landscape and defence production must accelerate to meet surging demand for platforms and equipment. Industry needs to adapt to ensure it gets its products into the hands of the end user, Evelyn Rafferty, Senior Director Aerospace and Defence - Europe at Plexus told Shephard’s Gerrard Cowan.
-
![Delays, departures and drama cloud UK defence programmes ahead of absent DIP]()
Delays, departures and drama cloud UK defence programmes ahead of absent DIP
The UK defence secretary’s departure suggests that the long-delayed Defence Investment Plan is unlikely to meet the funding demands of the armed forces, with consequences for procurement and the UK’s standing at a NATO summit weeks away.
